etoposide has been researched along with bromodeoxyuridine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Banáth, JP; Olive, PL | 1 |
| Igarashi, Y; Ishiyama, K; Kumagai, H; Sasaki, H; Satoh, S; Yahagi, A | 1 |
| Chwalinski, M; Cohen, GM; Fearnhead, HO; Ormerod, MG; Snowden, RT | 1 |
| Bleehen, NM; Falk, SJ; Gottlieb, T; Osborne, RJ; Smith, PJ; Souès, S; Watson, JV | 1 |
| Armstrong, MJ; Bean, CL; Galloway, SM; Miller, JE; Nichols, WW; Skopek, TR | 1 |
| Alm, K; Oredsson, SM | 1 |
| Fujise, K; Liu, J; Yeh, ET; Zhang, D | 1 |
| Mizutani, S; Oshimi, K; Sasaki, M; Sugimoto, K; Takagi, M; Tamayose, K; Yamada, K | 1 |
| Kao, GD; McKenna, WG; Yen, TJ | 1 |
| Adler, ID; Attia, SM; Badary, OA; Hamada, FM; Schmid, TE | 1 |
| Kavurma, MM; Khachigian, LM | 1 |
| Agostinho, M; Braga, J; Ferreira, F; Ferreira, J; Rino, J; Steffensen, S | 1 |
| Barbier, M; Bignon, J; Boutonnat, J; Colle, PE; Faussat, AM; Marie, JP; Ronot, X; Thierry, J; Wdzieczak-Bakala, J | 1 |
| Anderson, MA; Bowman, M; Deb, S; Deb, SP; Hassan, S; Miles, MF; Scian, MJ; Stagliano, KE | 1 |
| Bohr, VA; Christmann, M; Gestrich, C; Kaina, B; Roos, WP; Tomicic, MT | 1 |
| Doi, K; Nakayama, H; Nam, C | 1 |
19 other study(ies) available for etoposide and bromodeoxyuridine
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Growth fraction measured using the comet assay.
Topics: Animals; Bromodeoxyuridine; Cell Division; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Etoposide; Fluorescent Antibody Technique; Humans; Mice; Mice, Nude; Microscopy, Fluorescence; Tumor Cells, Cultured | 1992 |
Flow cytometric analysis of the cell cycle of the leukemic cell lines treated with etoposide and cytosine arabinoside.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Cytarabine; DNA Replication; DNA, Neoplasm; Etoposide; Flow Cytometry; Humans; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured | 1994 |
Dexamethasone and etoposide induce apoptosis in rat thymocytes from different phases of the cell cycle.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Separation; Dexamethasone; Etoposide; Male; Rats; Rats, Inbred F344; T-Lymphocytes | 1994 |
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Topics: Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Flow Cytometry; G1 Phase; Genes, p53; Humans; Kinetics; Lung Neoplasms; Mutation; S Phase; Tumor Cells, Cultured | 1994 |
DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens.
Topics: Animals; Aphidicolin; Bromodeoxyuridine; Cell Count; Cell Cycle; CHO Cells; Chromosome Aberrations; Cricetinae; DNA; Etoposide; Flow Cytometry; Mutagenicity Tests; Mutagens; Nucleic Acid Synthesis Inhibitors; Topoisomerase I Inhibitors | 1998 |
The organization of replicon clusters is not affected by polyamine depletion.
Topics: Amanitins; Amidines; Animals; Antibodies, Monoclonal; Aphidicolin; Bromodeoxyuridine; CHO Cells; Cricetinae; DNA Replication; Eflornithine; Etoposide; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Indans; Microscopy, Confocal; Polyamines; Replicon; S Phase | 2000 |
Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen.
Topics: Amino Acid Sequence; Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Line; Cloning, Molecular; Etoposide; Fluorescent Antibody Technique, Indirect; Gene Library; HeLa Cells; Humans; Mice; Microscopy, Confocal; Molecular Sequence Data; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Precipitin Tests; Proliferating Cell Nuclear Antigen; Protein Binding; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Sequence Homology, Amino Acid; Tumor Cells, Cultured; Two-Hybrid System Techniques | 2000 |
Activation of an ataxia telangiectasia mutation-dependent intra-S-phase checkpoint by anti-tumour drugs in HL-60 and human lymphoblastoid cells.
Topics: Antimetabolites; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Bromodeoxyuridine; Caffeine; Cell Cycle Proteins; Cell Line, Transformed; Cytarabine; DNA-Binding Proteins; Doxorubicin; Etoposide; Flow Cytometry; Gene Expression; HL-60 Cells; Humans; Mutation; Phosphodiesterase Inhibitors; Protein Serine-Threonine Kinases; S Phase; Signal Transduction; Topoisomerase II Inhibitors; Tumor Suppressor Proteins | 2000 |
Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells.
Topics: Bromodeoxyuridine; Cell Cycle; Centromere; Chromosomal Proteins, Non-Histone; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; Female; Flow Cytometry; G2 Phase; Gamma Rays; HeLa Cells; Humans; Kinetics; Microfilament Proteins; Ovarian Neoplasms; Radiation Tolerance; Tumor Cells, Cultured | 2001 |
Molecular cytogenetic analysis in mouse sperm of chemically induced aneuploidy: studies with topoisomerase II inhibitors.
Topics: Aneuploidy; Animals; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Chromosome Aberrations; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epididymis; Etoposide; Image Processing, Computer-Assisted; In Situ Hybridization, Fluorescence; Male; Meiosis; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Spermatocytes; Thiobarbiturates; Topoisomerase II Inhibitors | 2002 |
Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
Topics: Animals; Apoptosis; Arteries; Blotting, Western; Bromodeoxyuridine; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cell Line; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Endothelium, Vascular; Etoposide; Genes, Dominant; Mutation; Myocytes, Smooth Muscle; Nucleic Acid Synthesis Inhibitors; Oligonucleotides, Antisense; Phosphorylation; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred WKY; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sp1 Transcription Factor; Time Factors; Transcription, Genetic; Zinc Fingers | 2003 |
Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis.
Topics: Antigens, Neoplasm; Autoantigens; Bromodeoxyuridine; Catalytic Domain; Cell Nucleus; Centromere Protein A; Centrosome; Chromosomal Proteins, Non-Histone; DNA Replication; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; HeLa Cells; Heterochromatin; Histone Deacetylases; Humans; Hydroxamic Acids; Interphase; Intranuclear Space; Microscopy, Confocal; Microscopy, Fluorescence; Mitosis; Razoxane; RNA Polymerase II | 2004 |
Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP.
Topics: Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Cell Proliferation; Cytarabine; Daunorubicin; DNA; Etoposide; Flow Cytometry; Fluorescent Dyes; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrocarbons, Chlorinated; Leukemia; Leukemia, Myeloid, Acute; Microscopy, Fluorescence; Oligopeptides; Organic Chemicals; Radiation-Protective Agents | 2005 |
Tumor-derived p53 mutants induce NF-kappaB2 gene expression.
Topics: Adenoviridae; Bromodeoxyuridine; Cell Line, Tumor; Cell Nucleus; Cloning, Molecular; Disease Progression; DNA, Complementary; Etoposide; Exons; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mutation; NF-kappa B; NF-kappa B p52 Subunit; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; RNA; RNA, Small Interfering; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2005 |
WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Bone Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Survival; Colony-Forming Units Assay; DNA Breaks; DNA Repair; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Exodeoxyribonucleases; Histones; Humans; Osteosarcoma; RecQ Helicases; RNA, Small Interfering; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured; Werner Syndrome Helicase | 2008 |
Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Division; DNA Damage; DNA-Binding Proteins; Etoposide; Female; Fetal Stem Cells; Fetus; G2 Phase; Maternal Exposure; Mice; Mice, Inbred ICR; Mice, Knockout; Neurons; Pregnancy; Protein Serine-Threonine Kinases; Telencephalon; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2010 |